Connect with us

Health

The Benefit of Resuming Use of the J&J COVID-19 Vaccine – University of Utah Health Care

The CDC and the FDA recommended restarting use of the Johnson & Johnson vaccine on April 23, 2021, after a temporary pause. After carefully reviewing the data,…

Published

on

Article feature image

May 07, 2021 10:00 AM
Author:
Kylene Metzger
The Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) recommended restarting use of the Johnson & Johnson vaccine on April 23, 2021, after a temporary pause. The pause followed reports of a rare adverse event called thrombosis with thrombocytopenia syndrome (TTS), or vaccine-induced thrombotic thrombocytopenia (VITT), which causes blood clots with low platelets among a small number of people, mostly women younger…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending